Amgen Inc.
Fc VARIANTS

Last updated:

Abstract:

Disclosed are Fc-containing proteins comprising a binding region and a variant Fc region that can elicit one or more immune effector function and/or bind to an Fc receptor more effectively than a similar Fc-containing protein comprising a wild type Fc region. Also disclosed are nucleic acids encoding such Fc-containing proteins, methods for making such proteins, and methods of treatment utilizing such proteins.

Status:
Application
Type:

Utility

Filling date:

16 May 2019

Issue date:

9 Jan 2020